Trilogy writers are all degree-trained scientists and skilled in preparing documentation for any therapeutic area and indication.
We write for a global clientele, from small biotech companies to multinational pharmaceutical companies and clinical research organisations (CROs).
Our expertise comes from years of experience working in all phases of clinical development, which brings the depth of understanding needed to effectively communicate specific messages for varied documents.
We are equally at ease writing about pharmacokinetics and pharmacodynamics as we are writing reports of clinical efficacy and safety or epidemiology.
In addition to our experience in conventional drug therapies, we have experience in novel therapies, including stem cells and other cell cultures, parasites, and gene therapy (mRNA) treatments.
Trilogy writers are fully conversant with International Conference on Harmonisation (ICH) and Good Clinical Practice (GCP) standards that apply to activities of medical writing, as well as European, US, and other local regulatory requirements and all our documentation complies with these standards.
Dr Barry Drees (Senior Partner)